Search Results
Aug 19, 2026, 03:50 ET Piramal Pharma Limited、Yapan Bio Private Limitedの支配持ち分の取得を完了
-- Piramal Pharma Ltd. （NSE：PPLPHARMA）（BSE：543635) （「PPL」）は、ハイデラバードに拠点を置き、ワクチンおよびバイオ医薬品を専門とするCDMOであるYapan Bio Private Limited（「Yapan Bio」）の株式の40.67％を追加取得しました。買収総額は現金₹76cr INR （795万米ドル）です。本取引の結果、PPLは現在、Yapan Bioの株式の74% を保有しており、Yapan BioはPPLの子会社となります。
More news about: Piramal Pharma Solutions
Aug 18, 2026, 21:00 ET Antengene Presents Key R&D Highlights at the Evercore 2nd China Biotech Summit
(26/30), and the mOS was not yet reached, with a median follow–up of 14.03 months. One patient in each of the two dose groups achieved a complete response (CR).Favorable safety profile: Compared with the data cutoff of December 25, 2025, the incidence of Grade ≥3 treatment–related
More news about: Antengene Corporation Limited
Aug 18, 2026, 08:44 ET Maynards Announces Clintwood JOD Multi-Million-Dollar Mining Equipment Auction
purchasing new machinery.Featured equipment includes Caterpillar D10T2 and D11 crawler dozers; Caterpillar 992 and 988K wheel loaders; Caterpillar 308CR and Komatsu PC490LC-10 excavators; Caterpillar 16M and 16G motor graders; Caterpillar 785D and 777D haul trucks; Superior Highwall Miners; and Atlas
More news about: Maynards Group of Companies
Aug 17, 2026, 22:30 ET upGrad Crosses ₹2,000 Cr Gross Revenue in FY26; Grows EBITDA 8X to 123 Cr
multimedia:https://www.prnewswire.com/in/news-releases/upgrad-crosses-2-000-cr-gross-revenue-in-fy26-grows-ebitda-8x-to-123-cr-302853040.html
More news about: upGrad
Aug 17, 2026, 09:56 ET 科倫博泰宣佈2026年中期業績
非DC產品SKB118/CR-001(PD-1/VEGF雙抗): 治療實體瘤的IND申請獲NMPA批准，且1/2期臨床試驗正在中國進行SKB378/WIN378(TSLP單抗): 已在中國健康受試者中完成1期臨床試驗，其治療COPD的IND申請亦獲NMPA批准SKB575(TSLP/未披露靶點雙抗):
More news about: 科倫博泰
Aug 17, 2026, 09:03 ET Crunch Fitness Franchise Group Nears 65 Clubs in Florida with Crunch Maitland Opening
milestone in CR Fitness Holdings' continued expansion across Florida, with additional Crunch Fitness locations planned for the state including: Kissimmee West, Viera, Haines City, and St. Cloud.About CR Fitness Holdings, LLC CR Fitness Holdings LLC, a subsidiary of CR Fitness Holdings,
More news about: CR Fitness Holdings, LLC.
Aug 17, 2026, 09:00 ET Paramount Skydance Corporation Announces Extension of Expiration Dates of Previously Announced Exchange Offers and Tender Offers
DCL Issuer25470D CR8US25470DCR89
More news about: Paramount Skydance Corporation
Aug 17, 2026, 08:00 ET CARFAX: Which Vehicles are the Most Reliable?
cars with an estimated likelihood of unexpected repairs of roughly 2%, less than half the segment average of 5.5%.SUVs: Honda CR-V, Kia Sportage, and Mitsubishi Eclipse CrossEach ranked among the most reliable SUVs with an estimated likelihood of unexpected
More news about: CARFAX
Aug 17, 2026, 07:18 ET Kelun-Biotech Announces 2026 Interim Results
among others.Non-DC AssetsClinical progress in the reporting period:SKB118/CR-001 (PD-1/VEGF bsAb): The IND application for the treatment of solid tumors has been approved by the NMPA, and a Phase 1/2 clinical trial
More news about: Kelun-biotech
Aug 16, 2026, 20:00 ET AbelZeta Regains Global Rights of C-CAR039 (Prizlon-cel) and Receives FDA Clearance of IND Application in Large B-cell Lymphoma
in China demonstrated a favorable safety profile and deep and durable responses, with an overall response rate (ORR) of 91.5% and complete response (CR) rate of 85.1%. Median PFS was 60.1 months at a median follow-up of 53.9 months."We are pleased to welcome C-CAR039 back to our hematology malignancy
More news about: AbelZeta Pharma, Inc.
Aug 14, 2026, 16:30 ET Citius Oncology, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
presented at 2026 ASTCT® & CIBMTR® Tandem Meetings, demonstrating:86% ORR, including 57% complete response (CR) and 29% partial response (PR),LYMPHIR was well-tolerated with no dose-limiting toxicities observed; and,Appointed
More news about: Citius Oncology, Inc.
Aug 14, 2026, 16:30 ET Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
CAR-T therapy in high-risk relapsed or refractory diffuse large B-cell lymphoma (DLBCL):86% ORR, including 57% complete response (CR) and 29% partial response (PR),LYMPHIR was well-tolerated with no dose-limiting toxicities observed;Closed a registered
More news about: Citius Pharmaceuticals, Inc.
Aug 14, 2026, 06:53 ET AXISCADES reports record Rs. 346.7 crore revenue from operations for Q1 FY27, including discontinued operations, up 42.2% YoY
movements and final accounting determination.Deferred Revenue UpdateManagement estimates that approximately Rs. 64 cr of the Rs. 142 crore of FY26 revenue deferred for supply-chain and operational reasons was recognised in Q1 FY27. Management expects to recognise the
More news about: Axiscades Technologies Limited
Aug 12, 2026, 13:31 ET McCune Law Group Investigating Civil Claims for Families of Children Assaulted at the Amador County Fair
Guillermo Carrillo, has been charged in Amador County Superior Court with 21 felony counts involving acts against minors under the age of 14 (Case No. 26CR36775). The criminal investigation is being led by the Amador County Sheriff's Office, and additional families have already come forward. McCune Law Group's
More news about: McCune Law Group APC
Aug 07, 2026, 16:05 ET Paramount Skydance Corporation Announces Extension of Expiration Dates of Previously Announced Exchange Offers and Tender Offers
DCL Issuer25470D CR8US25470DCR89
More news about: Paramount Skydance Corporation
Aug 06, 2026, 17:00 ET Canada Nickel Reports Additional Exploration Drilling Results and Highest Grade Intervals to Date at Reid Nickel Sulphide Project
Pt g/tCr %Fe %
More news about: Canada Nickel Company Inc.
Aug 06, 2026, 16:15 ET Corteva Announces Private Exchange Offers and Consent Solicitations for EIDP's 2.300% Senior Notes Due 2030, 5.125% Senior Notes Due 2032 and 4.800% Senior Notes Due 2033
263534CR8 US263534CR89$
More news about: Corteva Agriscience
Aug 06, 2026, 09:06 ET Mercury Insurance Reveals the 10 Most Affordable New Electric and Hybrid Vehicles to Insure for 2026
5Honda CR-V Hybrid6
More news about: Mercury Insurance
Aug 06, 2026, 06:18 ET Afcons receives LoA for ₹1,918-cr desalinated water tunnel project in Mumbai
multimedia:https://www.prnewswire.com/in/news-releases/afcons-receives-loa-for-1-918-cr-desalinated-water-tunnel-project-in-mumbai-302844871.html
More news about: Afcons Infrastructure Limited
Aug 06, 2026, 00:30 ET Vasuki India Raises ₹100 Crore from an NRI Investor, Extends Fund Raise until December'2026
Vasuki India, a SEBI Category III Alternative Investment Fund (AIF), nearing closure of its drawdown period, is planning to raise further ~₹ 200cr in next few months.This investment comes as investors increasingly seek differentiated investment strategies that combine institutional discipline
More news about: Vasuki Hind Capital Private Limited
Aug 04, 2026, 04:57 ET Sisram Medical Powers Up China EBD Growth Engine with Flagship "黑金牛奶光" Launch
黑金牛奶光 is engineered to address this dual imperative by integrating high-purity DPL spectrum technology with advanced CR photofacial technology. Clinical studies have confirmed its potential to organically combine targeted treatment of specific skin concerns with ongoing
More news about: Sisram Medical Ltd
Aug 02, 2026, 10:01 ET New Chemotherapy-Free Immunotherapy Combination for Follicular Lymphoma Listed on the PBS
in the FL population, and the key secondary endpoints are PFS in the overall population as well as positron emission tomography complete response (PET-CR) and overall survival (OS) in the FL population.The clinical trial met its primary endpoint, with the data demonstrating a statistically significant
More news about: Specialised Therapeutics
Jul 31, 2026, 16:01 ET Paramount Skydance Corporation Announces Extension of Expiration Dates of Previously Announced Exchange Offers and Tender Offers
DCL Issuer25470D CR8US25470DCR89
More news about: Paramount Skydance Corporation
Jul 31, 2026, 08:13 ET Afcons secures projects worth nearly ₹900 Cr in July
download multimedia:https://www.prnewswire.com/in/news-releases/afcons-secures-projects-worth-nearly-900-cr-in-july-302839999.html
More news about: Afcons Infrastructure Limited
Jul 31, 2026, 07:47 ET AbbVie Reports Second-Quarter 2026 Financial Results
survival (PFS) and overall response rates (ORR) compared to R2, with approximately three out of four patients achieving a complete response (CR). This approval marks the first bispecific-based therapy approved in Europe for the treatment of R/R FL in the second-line setting, offering patients
More news about: AbbVie